Table 2.
Baseline and presenting characteristics of the study patients in the reflow and no-reflow groups*
| No-Reflow Group (n=166) |
Reflow Group (n=364) |
P | |
|---|---|---|---|
| Age (y) | 59.89±12.32 | 57.30±12.34 | 0.025 |
| Men | 136 (81.9) | 280 (76.9) | 0.193 |
| Diabetes mellitus | 48 (28.9) | 104 (28.6) | 0.935 |
| Hypertension | 86 (51.8) | 220 (60.4) | 0.062 |
| Hyperlipidemia | 95 (57.9) | 219 (60.5) | 0.578 |
| Smoking cigarettes | 55/160 (34.4) | 132/361 (36.6) | 0.631 |
| Family history of CAD | 23 (13.9) | 66/363 (18.2) | 0.227 |
| Body mass index, kg/m2 | 27.00±3.47 | 26.97±3.97 | 0.927 |
| Previous myocardial infarction | 5 (3.0) | 23 (6.3) | 0.114 |
| Pre-infarction angina | 144 (87.3) | 320 (87.9) | 0.836 |
| Pre-infarction angina class III/IV | 133 (80.6) | 295 (81.0) | 0.906 |
| Anterior STEMI | 80 (48.2) | 138 (37.9) | 0.026 |
| Number of ECG leads with the Q wave | 3 (0.4) | 2 (0.3) | <0.001 |
| Use of statins | 150 (90.4) | 347 (95.3) | 0.028 |
CAD, Coronary artery disease; STEMI, ST-segment elevation myocardial infarction; ECG, Electrocardiography
*
Data are presented as mean±SD or n (%).